Skip to content

Novavax NVAX Net debt / EBITDA

Net debt / EBITDA at other companies

Moderna logo
ModernaMRNA
-2.8×-2.9×
Roivant Sciences logo
Roivant SciencesROIV
-0×
Merck & Co. logo
Merck & Co.MRK
+1.7×
ALN
Alnylam PharmaceuticalsALNY
-1.8×
Gilead Sciences logo
Gilead SciencesGILD
1.4×-0.6×
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-0.2×

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

Based on the most recent quarter.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's net debt / EBITDA?
Novavax (NVAX) reported net debt / EBITDA of 0.1× in Q4 2025.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.